Meta-analysis ofKRASmutations and survival after resection of colorectal liver metastases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analysis ofKRASmutations and survival after resection of colorectal liver metastases
Authors
Keywords
-
Journal
BRITISH JOURNAL OF SURGERY
Volume 102, Issue 10, Pages 1175-1183
Publisher
Wiley
Online
2015-07-21
DOI
10.1002/bjs.9870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- RAS Mutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases
- (2014) Yoshihiro Mise et al. ANNALS OF SURGICAL ONCOLOGY
- KRASmutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
- (2014) Kjetil Søreide et al. CANCER
- KRASmutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
- (2014) Nancy E. Kemeny et al. CANCER
- Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection
- (2014) Hirokazu Shoji et al. CANCER SCIENCE
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
- (2013) Jean-Nicolas Vauthey et al. ANNALS OF SURGERY
- MACC1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases
- (2013) Claudio Isella et al. ANNALS OF SURGERY
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases
- (2013) Georgios Karagkounis et al. CANCER
- Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer
- (2013) Brian C. Netzel et al. CLINICA CHIMICA ACTA
- Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy Cetuximab
- (2013) C. G. Smith et al. CLINICAL CANCER RESEARCH
- KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials
- (2013) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases
- (2012) Steven C. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
- (2012) Y Kawamoto et al. BRITISH JOURNAL OF CANCER
- KRASstatus and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab
- (2012) S. Stremitzer et al. BRITISH JOURNAL OF SURGERY
- Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases
- (2012) Junichi Shindoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
- (2012) Efsevia Vakiani et al. JOURNAL OF CLINICAL ONCOLOGY
- Poor prognosis ofKRASorBRAFmutant colorectal liver metastasis without microsatellite instability
- (2012) Yuzo Umeda et al. Journal of Hepato-Biliary-Pancreatic Sciences
- BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
- (2012) Hao-Wei Teng et al. JOURNAL OF SURGICAL ONCOLOGY
- KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
- (2011) N Knijn et al. BRITISH JOURNAL OF CANCER
- KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
- (2011) J. Tie et al. CLINICAL CANCER RESEARCH
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
- (2011) Cecily P. Vaughn et al. GENES CHROMOSOMES & CANCER
- High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome
- (2011) Antoine Brouquet et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
- (2011) Eleni Makrodouli et al. Molecular Cancer
- KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications
- (2010) Antoine Italiano et al. ANNALS OF SURGICAL ONCOLOGY
- Conditional Survival after Surgical Resection of Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 949 Patients
- (2010) Hari Nathan et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase C Inhibitor Enzastaurin in Colon Cancer Cells
- (2010) M. Serova et al. MOLECULAR CANCER THERAPEUTICS
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
- (2009) Myrddin Rees et al. ANNALS OF SURGERY
- A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer
- (2009) Michael W. Kattan et al. ANNALS OF SURGERY
- KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
- (2009) Garrett M. Nash et al. ANNALS OF SURGICAL ONCOLOGY
- Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases
- (2009) Christoph Reissfelder et al. ANNALS OF SURGICAL ONCOLOGY
- Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
- (2009) Yun Shin Chun JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
- (2009) Paloma Cejas et al. PLoS One
- Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
- (2008) Dan G. Blazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More